Prognostic significance of MRI contrast enhancement in newly diagnosed glioblastoma, IDH-wildtype according to WHO 2021 classification
Journal of Neuro-Oncology · 2024-09 · 169 (2) · 445-455
DOI: 10.1007/s11060-024-04747-7 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of Neuro-Oncology, online erschienen am 24.06.2024. Verfasst von Alexandre Roux und 11 weiteren Autor:innen. Beteiligte Einrichtung: Service de Neurochirurgie, GHU-Paris Psychiatrie et Neurosciences, Site Sainte Anne, 1, rue Cabanis, Paris Cedex 14, F-75014, France. alexandre.roux@…. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms, Magnetic Resonance Imaging, Isocitrate Dehydrogenase. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND AND OBJECTIVES: Contrast enhancement in glioblastoma, IDH-wildtype is common but not systematic. In the era of the WHO 2021 Classification of CNS Tumors, the prognostic impact of a contrast enhancement and the pattern of contrast enhancement is not clearly elucidated. METHODS: We performed an observational, retrospective, single-centre cohort study at a tertiary neurosurgical oncology centre (January 2006 - December 2022). We screened adult patients with a newly-diagnosed glioblastoma, IDH-wildtype in order to assess the prognosis role of the contrast enhancement and the pattern of contrast enhancement. RESULTS: We included 1149 glioblastomas, IDH-wildtype: 26 (2.3%) had a no contrast enhancement, 45 (4.0%) had a faint and patchy contrast enhancement, 118 (10.5%) had a nodular contrast enhancement, and 960 (85.5%) had a ring-like contrast enhancement. Overall survival was longer in non-contrast enhanced glioblastomas (26.7 months) than in contrast enhanced glioblastomas (10.9 months) (p < 0.001). In contrast enhanced glioblastomas, a ring-like pattern was associated with shorter overall survival than in faint and patchy and nodular patterns (10.0 months versus 13.0 months, respectively) (p = 0.033). Whatever the presence of a contrast enhancement and the pattern of contrast enhancement, surgical resection was an independent predictor of longer overall survival, while age ≥ 70 years, preoperative KPS score < 70, tumour volume ≥ 30cm3, and postoperative residual contrast enhancement were independent predictors of shorter overall survival. CONCLUSION: A contrast enhancement is present in the majority (97.7%) of glioblastomas, IDH-wildtype and, regardless of the pattern, is associated with a shorter overall survival. The ring-like pattern of contrast enhancement is typical in glioblastomas, IDH-wildtype (85.5%) and remains an independent predictor of shorter overall survival compared to other patterns (faint and patchy and nodular).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Service de Neurochirurgie, GHU-Paris Psychiatrie et Neurosciences, Site Sainte Anne, 1, rue Cabanis, Paris Cedex 14, F-75014, France. alexandre.roux@neurochirurgie.fr.
- Institute of Psychiatry and Neuroscience of Paris (IPNP), Université Paris Cité, INSERM U1266, IMA-Brain, Paris, F-75014, France. alexandre.roux@neurochirurgie.fr.
- Service de Neurochirurgie, GHU-Paris Psychiatrie et Neurosciences, Site Sainte Anne, 1, rue Cabanis, Paris Cedex 14, F-75014, France.
- Institute of Psychiatry and Neuroscience of Paris (IPNP), Université Paris Cité, INSERM U1266, IMA-Brain, Paris, F-75014, France.
- Service de Neuroradiologie, GHU Paris Psychiatrie et Neurosciences, Site Sainte Anne, Paris, F- 75014, France.
- Service de Neuropathologie, GHU Paris Psychiatrie et Neurosciences, Site Sainte-Anne, Paris, F- 75014, France.
Zitieren
APA
Roux, A., Elia, A., Hudelist, B., Benzakoun, J., Dezamis, E., Parraga, E., Moiraghi, A., Simboli, G. A., Chretien, F., Oppenheim, C., Zanello, M., & Pallud, J. (2024). Prognostic significance of MRI contrast enhancement in newly diagnosed glioblastoma, IDH-wildtype according to WHO 2021 classification. Journal of Neuro-Oncology, 169(2), 445-455. https://doi.org/10.1007/s11060-024-04747-7
Vancouver
Roux A, Elia A, Hudelist B, Benzakoun J, Dezamis E, Parraga E, et al. Prognostic significance of MRI contrast enhancement in newly diagnosed glioblastoma, IDH-wildtype according to WHO 2021 classification. Journal of Neuro-Oncology. 2024;169(2):445-455. doi:10.1007/s11060-024-04747-7
BibTeX
@article{Roux2024,
author = {Roux, Alexandre and Elia, Angela and Hudelist, Benoit and Benzakoun, Joseph and Dezamis, Edouard and Parraga, Eduardo and Moiraghi, Alessandro and Simboli, Giorgia Antonia and Chretien, Fabrice and Oppenheim, Catherine and Zanello, Marc and Pallud, Johan},
title = {Prognostic significance of MRI contrast enhancement in newly diagnosed glioblastoma, IDH-wildtype according to WHO 2021 classification},
journal = {Journal of Neuro-Oncology},
year = {2024},
volume = {169},
number = {2},
pages = {445--455},
doi = {10.1007/s11060-024-04747-7}
}
EUVIMED